Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.69 |
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.54 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.51 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.50 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.50 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27320205 | 0.98 | ALDH1A1 (0.68) | ALDH1A1HTTTP53KMT2APTK2B | |
| SCHEMBL27344933 | 0.98 | ALDH1A1 (0.68) | ALDH1A1HTTTP53KMT2APTK2B | |
| Salicylic Acid SCHEMBL31052931 | 0.97 | ALDH1A1 (0.66) | ALDH1A1HTTTP53KMT2APTK2B | |
| Salicylic Acid SCHEMBL30476656 | 0.97 | ALDH1A1 (0.66) | ALDH1A1HTTTP53KMT2APTK2B | |
| Salicylamide SCHEMBL28057428 | 0.91 | ALDH1A1 (0.59) | ALDH1A1HTTTP53KMT2APTK2B | |
| Salicylic Acid SCHEMBL3879225 | 0.91 | ALDH1A1 (0.59) | ALDH1A1HTTTP53KMT2APTK2B | |
| SCHEMBL2467710 | 0.91 | KDM4E (0.66) | ALDH1A1HTTTP53KMT2APTK2B | |
| SCHEMBL27914372 | 0.88 | ALDH1A1 (0.56) | ALDH1A1HTTTP53KMT2APTK2B | |
| SCHEMBL14735475 | 0.86 | ALDH1A1 (0.52) | ALDH1A1HTTTP53KMT2AFOLH1 | |
| SCHEMBL11792088 | 0.85 | ALDH1A1 (0.51) | ALDH1A1HTTTP53KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3113 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025066019-A1 | TOPICAL DELIVERY COMPOSITIONS COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | ANDROS PHARMACEUTICALS CO., LTD. (CN) | 2025-04-03 | — | — | WO | claimed |
| EP-4529917-A1 | TOPICAL DELIVERY COMPOSITIONS COMPRISING NON-STEROIDAL ANTI-INLAMMATORY DRUGS | Andros Pharmaceuticals Co., Ltd. (TW) | 2025-04-02 | — | — | EP | claimed |
| US-20250099369-A1 | TOPICAL DELIVERY COMPOSITIONS COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | ANDROS PHARMACEUTICALS CO., LTD. (TW) | 2025-03-27 | — | — | US | claimed |
| WO-2025030142-A2 | METHODS OF TREATMENT USING OXYTOCIN | BELNAP PHARMACEUTICALS, LLC (US) | 2025-02-06 | — | — | WO | claimed |
| EP-3508501-B1 | USE OF ANTI-CGRP ANTIBODIES AND ANTIBODY FRAGMENTS TO PREVENT OR INHIBIT PHOTOPHOBIA OR LIGHT AVERSION IN SUBJECTS IN NEED THEREOF, ESPECIALLY MIGRAINE SUFFERERS | H LUNDBECK AS (DK) | 2024-11-06 | — | — | EP | claimed |
| EP-3682872-B1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2024-01-03 | — | — | EP | claimed |
| WO-2023204482-A1 | ION CONDUCTOR DISPERSION, POLYMER ELECTROLYTE MEMBRANE PREPARED THEREFROM, MEMBRANE-ELECTRODE ASSEMBLY, AND FUEL CELL | 코오롱인더스트리 주식회사 | 2023-10-26 | — | — | WO | claimed |
| US-11771695-B2 | Cannabinoid receptor modulators | ARENA PHARMACEUTICALS, INC. (US) | 2023-10-03 | — | — | US | claimed |
| US-11478497-B2 | Methods and compositions for treating eukaryotic infections via altering aggregation dynamics of Raptor/KOG1 | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2022-10-25 | — | — | US | claimed |
| EP-3385252-B1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARM INC (US) | 2022-09-21 | — | — | EP | claimed |
| EP-0249561-B1 | COMPOSITIONS USING LIPOSOME-ENCAPSULATED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | THE LIPOSOME COMPANY, INC. (US) | 1992-05-13 | — | — | EP | claimed |
| WO-1987007506-A1 | METHODS AND COMPOSITIONS USING LIPOSOME-ENCAPSULATED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | THE LIPOSOME COMPANY, INC. (US) | 1987-12-17 | — | — | WO | claimed |
| EP-0249561-A2 | Compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs | THE LIPOSOME COMPANY, INC. (US) | 1987-12-16 | — | — | EP | claimed |
| EP-0046270-B1 | NOVEL DERIVATIVES OF BIO-AFFECTING PHENOLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | INTERx RESEARCH CORPORATION (US) | 1986-05-21 | — | — | EP | claimed |
| US-4483854-A | Systemic treatment of psoriasis using certain salicylates | KEY PHARMACEUTICALS, INC. (US) | 1984-11-20 | — | — | US | claimed |
| EP-0066918-A1 | Anti-inflammatory compositions exhibiting minimized gastric damage | THE PROCTER & GAMBLE COMPANY (US) | 1982-12-15 | — | — | EP | claimed |
| EP-0046270-A1 | Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them | INTERx RESEARCH CORPORATION (US) | 1982-02-24 | — | — | EP | claimed |
| US-4203619-A | HEATING THE COATING CONTAINING A CHROMOGENIC MATERIAL, COOLING AND SETTING; SOLVENT-FREE | THE MEAD CORPORATION (US) | 1980-05-20 | — | — | US | claimed |
| EP-0009046-A1 | COMPOSITION CONTAINING SALICYLSALICYCLIC ACID AND ACETAMINOPHEN | ZOBIAN, Ernest, P., Jr. (US) | 1980-04-02 | — | — | EP | claimed |
| WO-1979000556-A1 | COMPOSITION CONTAINING SALICYLSALICYLIC ACID AND ACETAMINOPHEN | ZOBIAN E | 1979-08-23 | — | — | WO | claimed |